We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
+10%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$44.5B
AUM Growth
-$1.18B
Cap. Flow
-$4.15B
Cap. Flow %
-9.34%
Top 10 Hldgs %
9.83%
Holding
3,927
New
652
Increased
690
Reduced
847
Closed
1,056

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$309M
2
XOM icon
ExxonMobil
XOM
+$302M
3
AMZN icon
Amazon
AMZN
+$291M
4
C icon
Citigroup
C
+$253M
5
SHOP icon
Shopify
SHOP
+$238M

Top Sells

Rank Stock Value
1
HUM icon
Humana
HUM
+$383M
2
JNJ icon
Johnson & Johnson
JNJ
+$312M
3
JPM icon
JPMorgan Chase
JPM
+$285M
4
T icon
AT&T
T
+$191M
5
DG icon
Dollar General
DG
+$187M

Sector Composition

Rank Sector Weight
1 Healthcare 15.63%
2 Financials 15.61%
3 Technology 14.28%
4 Consumer Discretionary 13.21%
5 Industrials 5.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GWII
3626
DELISTED
Good Works II Acquisition Corp. Common Stock
GWII
-734,151
Closed -$7.35M
RUBY
3627
DELISTED
Rubius Therapeutics, Inc
RUBY
-425,497
Closed -$184K
HPX.WS
3628
CALL
DELISTED
HPX Corp. Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
HPX.WS
-99,999
Closed -$992K
RNER
3629
DELISTED
Mount Rainier Acquisition Corp. Common Stock
RNER
-818,281
Closed -$8.27M
DCRDW
3630
CALL
DELISTED
Decarbonization Plus Acquisition Corporation IV Warrant
DCRDW
-199,995
Closed -$2.01M
SRNE
3631
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-293,934
Closed -$461K
DTRT
3632
DELISTED
DTRT Health Acquisition Corp. Class A Common Stock
DTRT
-1,063,189
Closed -$10.8M
PRBM
3633
DELISTED
Parabellum Acquisition Corp.
PRBM
-599,988
Closed -$5.93M
APN
3634
DELISTED
Apeiron Capital Investment Corp
APN
-414,637
Closed -$4.17M
DNZ
3635
DELISTED
D and Z Media Acquisition Corp.
DNZ
-1,323,417
Closed -$13.1M
RKLY.WS
3636
CALL
DELISTED
Rockley Photonics Holdings Limited Warrants, each warrant exercisable for one ordinary share at an exercise price of $11.50
RKLY.WS
-12,033
Closed -$8K
ARCK
3637
DELISTED
Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK
-724,590
Closed -$7.35M
TCDA
3638
DELISTED
Tricida, Inc. Common Stock
TCDA
-287,603
Closed -$3.02M
PRTY
3639
DELISTED
Party City Holdco Inc.
PRTY
-232,748
Closed -$368K
EPHY
3640
DELISTED
Epiphany Technology Acquisition Corp. Class A Common Stock
EPHY
-1,900,419
Closed -$18.8M
BRMK.WS
3641
CALL
DELISTED
Broadmark Realty Capital Inc. Warrants, each exercisable for one fourth (1/4th) share of Common Stock at an exercise price of $2.875 per quarter share
BRMK.WS
-400,000
Closed -$2.04M
GLS.WS
3642
CALL
DELISTED
Gelesis Holdings, Inc. Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
GLS.WS
-296,304
Closed -$320K
SPIR.WS
3643
CALL
DELISTED
Spire Global, Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per whole share
SPIR.WS
-100,000
Closed -$109K
CORZW
3644
CALL
DELISTED
Core Scientific, Inc. Warrant
CORZW
-100,000
Closed -$130K
DS
3645
DELISTED
Drive Shack Inc.
DS
-94,773
Closed -$59K
ASAX
3646
DELISTED
Astrea Acquisition Corp. Class A Common Stock
ASAX
-738,347
Closed -$7.27M
GIIX
3647
DELISTED
Gores Holdings VIII, Inc. Class A Common Stock
GIIX
-1,034,937
Closed -$10.2M
GIIXW
3648
CALL
DELISTED
Gores Holdings VIII, Inc. Warrant
GIIXW
-172,570
Closed -$1.7M
FACA
3649
DELISTED
Figure Acquisition Corp. I
FACA
-1,341,341
Closed -$13.2M
CLAS
3650
DELISTED
Class Acceleration Corp.
CLAS
-1,253,964
Closed -$12.4M

Similar funds

Marshall Wace's Q4 2022 Portfolio in Review

As of Q4 2022, Marshall Wace held 3,927 positions worth $44.5B, down 2.6% from $45.6B the previous quarter. Its ten largest holdings account for 9.8% of the portfolio.

Marshall Wace withdrew a net $4.15B in Q4 2022, closing 1,056 positions and reducing 847 holdings. Its most notable exit was Humana, an estimated $383M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Financials and Technology.

Against the trend, Marshall Wace opened a new position in Elevance Health worth $188M.

  • Marshall Wace's largest Q4 2022 buy was Elevance Health: 366,649 shares worth $188M.
  • Marshall Wace added most to Biogen in Q4 2022, an estimated $309M increase.
  • Marshall Wace's biggest Q4 2022 reduction was Johnson & Johnson, cutting an estimated $312M.
  • Marshall Wace fully exited Humana in Q4 2022, selling an estimated $383M.
  • Marshall Wace's ten largest holdings make up 9.8% of its $44.5B portfolio in Q4 2022.
  • Marshall Wace opened 652 new positions and closed 1,056 in Q4 2022.
  • Marshall Wace's portfolio value fell 2.6% quarter-over-quarter to $44.5B.

Based on Marshall Wace's 13F filing for Q4 2022, filed 14 Feb 2023.